To combat the burden of new regulatory requirements, operational challenges and renewed infrastructure needs, the life science industry must take a holistic and collaborative approach to achieving data disclosure compliance. Through data disclosure and transparency, life science organizations decrease the chances of clinical trial duplication, ensure public understanding and access, and ultimately promote brand integrity.
At the 2nd Disclosure and Transparency for Clinical Data Summit, the star-studded speaking faculty will define standardization processes for disclosure and registry, provide best practices to balance commercial confidentiality and public access, and examine proven tactics that preserve data utility while ensuring adequate anonymization. This summit will provide you with the tools to ultimately maximize the benefits of clinical data from the inherent risks of clinical trials, all while complying with national and global compliance regulations.
Speakers: Liz Roberts, Senior Director, Global Lead, Transparency and Data, Sharing, UCB, Sulochana Gawande, Head of Submission Writing and Director of Publications — Oncology Business Group, EISAI, Yolanda Davis, Quality Assurance Manager — Clinical Trial Disclosure, UNIVERSITY OF MIAMI, Oladayo Oyelola, Ph.D., SC (ASCP), Director, Clinical Trial Information Disclosure, DAIICHI SANKYO, INC., Nathaniel Root Associate Director, Clinical Disclosure and Transparency, IONIS PHARMACEUTICALS, INC., Frantz Derilus, Global Head of Disclosure and Transparency, GILEAD SCIENCES, Thomas Wicks, Chief Strategy Officer, TRIALSCOPE, Kristen Bolt, Former Project Manager, Data Sharing and Transparency, MULTI-REGIONAL CLINICAL TRIALS CENTER OF BRIGHAM AND WOMEN’S HOSPITAL AND HARVARD, Laura Troast, Director, Clinical Trial Registration and Results Disclosure, MERCK, Joseph Philipose, Vice President, U.S. and Enterprise Compliance, ALEXION, Behtash Bahador, Senior Manager, Quality and Compliance, CISCRP, Bryan Stefanski, Compliance Director, SIEMENS HEALTHCARE, Erik Lakes, Associate Director, Global Clinical Study Disclosure, TAKEDA
Time: 8:00 am to 5:00 pm
Conference Only - Early Bird Price before June 29, 2018: USD 1895.0
Conference Only - Standard Price after June 29, 2018: USD 2095.0
Conference Only - Onsite Price: USD 2195.0
2nd Disclosure and Transparency for Clinical Dat...
Reviews are public and modifiable.
Book your hotel with Bestrade and get access to exclusive offers.